Public-registry site landscape for NCT04739358, a Advanced Non-Small Cell Lung Cancer With MET Mutations study sponsored by Criterium, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04739358 (registry record) |
| Sponsor | Criterium, Inc. |
| Condition(s) | Advanced Non-Small Cell Lung Cancer With MET Mutations |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 5 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04739358 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →